
GC33099
BCRP-IN-1
Also known as (2S,5S,8S)-14-methoxy-5-methyl-2-(2-methylpropyl)-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
BCRP-IN-1 is a breast cancer resistance protein (BCRP) inhibitor with an IC50 of 0·6 μM on BCRP efflux transporter
ChemicalCAS1699720-85-8MW355.43FormulaC20H25N3O3
- CAS number
- 1699720-85-8
- Molecular weight
- 355.43
- Formula
- C20H25N3O3
- Solubility
- DMSO : ≥ 50 mg/mL (140·67 mM)
- InChIKey
- XDVXQQDQFWVCAU-GOPGUHFVSA-N
- Catalogue number
- GC33099
- Brand
- GLPBIO
Computed properties PubChem CID 91669184 · XLogP 2.7 · TPSA 74.4 Ų · H-bond donors 2
- XLogP
- 2.7
- TPSA
- 74.4 Ų
- H-bond donors
- 2
- H-bond acceptors
- 3
- Rotatable bonds
- 3
- Heavy atoms
- 26
SMILES C[C@H]1C(=O)N2[C@@H](CC3=C([C@@H]2CC(C)C)NC4=C3C=CC(=C4)OC)C(=O)N1
Computed descriptors from PubChem (CID 91669184), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il